A Clinical Protocol to Support the Gut–Lung Axis
Emerging research highlights the Gut–Lung Axis as a critical pathway in regulating both respiratory and systemic immunity. This bidirectional communication is mediated through microbial metabolites such as short-chain fatty acids (SCFAs), mucosal immune signaling, and inflammatory cascades. When the gut microbiome becomes imbalanced (dysbiosis), the result is reduced SCFA production,Read
